Regulation of myocardial growth and death by NADPH oxidase

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 3, 2011, Pages 408-416

  Maejima, Yasuhiro ^a   Kuroda, Junya ^a,b   Matsushima, Shouji ^a   Ago, Tetsuro ^a,b   Sadoshima, Junichi ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cardiac hypertrophy; Heart failure; Hydrogen peroxide; Mitochondria; Oxidative stress; Oxygen sensing; Superoxide

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

ANGIOGENESIS; APOPTOSIS; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART FAILURE; HEART MITOCHONDRION; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART VENTRICLE HYPERTROPHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; HEART; HEART FAILURE; HUMANS; MYOCARDIUM; NADPH OXIDASE;

EID: 79551588796     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.12.018     Document Type: Review

References (114)

1. McCord J.M., Fridovich I. The biology and pathology of oxygen radicals. Ann Intern Med 1978, 89:122-127.
2. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:500-508.
3. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 2003, 15:247-254.
4. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004, 4:181-189.
5. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
6. Babior B.M., Kipnes R.S., Curnutte J.T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Investig 1973, 52:741-744.
7. Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J 2008, 275:3249-3277.
8. Lambeth J.D., Kawahara T., Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 2007, 43:319-331.
9. Bendall J.K., Cave A.C., Heymes C., Gall N., Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 2002, 105:293-296.
10. Ago T., Kuroda J., Pain J., Fu C., Li H., Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res 2010, 106:1253-1264.
11. Cave A. Selective targeting of NADPH oxidase for cardiovascular protection. Curr Opin Pharmacol 2009, 9:208-213.
12. Hingtgen S.D., Tian X., Yang J., Dunlay S.M., Peek A.S., Wu Y., et al. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics 2006, 26:180-191.
13. Zhang M., Kho A.L., Anilkumar N., Chibber R., Pagano P.J., Shah A.M., et al. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 2006, 113:1235-1243.
14. Xiao L., Pimentel D.R., Wang J., Singh K., Colucci W.S., Sawyer D.B. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 2002, 282:C926-C934.
15. Satoh M., Ogita H., Takeshita K., Mukai Y., Kwiatkowski D.J., Liao J.K. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci USA 2006, 103:7432-7437.
16. Li J.M., Shah A.M. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem 2003, 278:12094-12100.
17. Frey R.S., Rahman A., Kefer J.C., Minshall R.D., Malik A.B. PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res 2002, 90:1012-1019.
18. Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000, 87:26-32.
19. Bayraktutan U., Blayney L., Shah A.M. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol 2000, 20:1903-1911.
20. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA 1997, 94:14483-14488.
21. Ushio-Fukai M., Tang Y., Fukai T., Dikalov S.I., Ma Y., Fujimoto M., et al. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002, 91:1160-1167.
22. Li J.M., Mullen A.M., Yun S., Wientjes F., Brouns G.Y., Thrasher A.J., et al. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res 2002, 90:143-150.
23. Abo A., Pick E., Hall A., Totty N., Teahan C.G., Segal A.W. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 1991, 353:668-670.
24. Uhlinger D.J., Taylor K.L., Lambeth J.D. p67-phox enhances the binding of p47-phox to the human neutrophil respiratory burst oxidase complex. J Biol Chem 1994, 269:22095-22098.
25. Ago T., Kuribayashi F., Hiroaki H., Takeya R., Ito T., Kohda D., et al. Phosphorylation of p47phox directs phox homology domain from SH3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation. Proc Natl Acad Sci USA 2003, 100:4474-4479.
26. Cave A.C., Brewer A.C., Narayanapanicker A., Ray R., Grieve D.J., Walker S., et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006, 8:691-728.
27. Quinn M.T., Evans T., Loetterle L.R., Jesaitis A.J., Bokoch G.M. Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components. J Biol Chem 1993, 268:20983-20987.
28. Geiszt M., Kopp J.B., Varnai P., Leto T.L. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 2000, 97:8010-8014.
29. Shiose A., Kuroda J., Tsuruya K., Hirai M., Hirakata H., Naito S., et al. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 2001, 276:1417-1423.
30. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004, 109:227-233.
31. Byrne J.A., Grieve D.J., Bendall J.K., Li J.M., Gove C., Lambeth J.D., et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 2003, 93:802-805.
32. Li J., Stouffs M., Serrander L., Banfi B., Bettiol E., Charnay Y., et al. The NADPH oxidase NOX4 drives cardiac differentiation: role in regulating cardiac transcription factors and MAP kinase activation. Mol Biol Cell 2006, 17:3978-3988.
33. Clempus R.E., Sorescu D., Dikalova A.E., Pounkova L., Jo P., Sorescu G.P., et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2007, 27:42-48.
34. Cucoranu I., Clempus R., Dikalova A., Phelan P.J., Ariyan S., Dikalov S., et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005, 97:900-907.
35. Carol R.J., Takeda S., Linstead P., Durrant M.C., Kakesova H., Derbyshire P., et al. A RhoGDP dissociation inhibitor spatially regulates growth in root hair cells. Nature 2005, 438:1013-1016.
36. Pawson T., Raina M., Nash P. Interaction domains: from simple binding events to complex cellular behavior. FEBS Lett 2002, 513:2-10.
37. Serrander L., Cartier L., Bedard K., Banfi B., Lardy B., Plastre O., et al. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 2007, 406:105-114.
38. Ambasta R.K., Kumar P., Griendling K.K., Schmidt H.H., Busse R., Brandes R.P. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 2004, 279:45935-45941.
39. Martyn K.D., Frederick L.M., von Loehneysen K., Dinauer M.C., Knaus U.G. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 2006, 18:69-82.
40. Lyle A.N., Deshpande N.N., Taniyama Y., Seidel-Rogol B., Pounkova L., Du P., et al. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 2009, 105:249-259.
41. Mahadev K., Motoshima H., Wu X., Ruddy J.M., Arnold R.S., Cheng G., et al. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol Cell Biol 2004, 24:1844-1854.
42. Dikalov S.I., Dikalova A.E., Bikineyeva A.T., Schmidt H.H., Harrison D.G., Griendling K.K. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 2008, 45:1340-1351.
43. Adler V., Yin Z., Tew K.D., Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111.
44. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M.D., Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA 2010, 107:15565-15570.
45. Lassegue B., Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003, 285:R277-R297.
46. Clempus R.E., Griendling K.K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 2006, 71:216-225.
47. Anilkumar N., Sirker A., Shah A.M. Redox sensitive signaling pathways in cardiac remodeling, hypertrophy and failure. Front Biosci 2009, 14:3168-3187.
48. Woo H.A., Yim S.H., Shin D.H., Kang D., Yu D.Y., Rhee S.G. Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell 2010, 140:517-528.
49. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Science's STKE: signal transduction knowledge environment 2006, re8.
50. Tsutsui H., Kinugawa S., Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 2009, 81:449-456.
51. Ide T., Tsutsui H., Kinugawa S., Utsumi H., Kang D., Hattori N., et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 1999, 85:357-363.
52. Halestrap A.P., Clarke S.J., Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 2004, 61:372-385.
53. Gupte S.A. Glucose-6-phosphate dehydrogenase: a novel therapeutic target in cardiovascular diseases. Curr Opin Investig Drugs 2008, 9:993-1000.
54. Santos C.X., Tanaka L.Y., Wosniak J., Laurindo F.R. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal 2009, 11:2409-2427.
55. George J., Struthers A.D. The role of urate and xanthine oxidase inhibitors in cardiovascular disease. Cardiovasc Ther 2008, 26:59-64.
56. Bergamini C., Cicoira M., Rossi A., Vassanelli C. Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail 2009, 11:444-452.
57. Kang S.M., Lim S., Song H., Chang W., Lee S., Bae S.M., et al. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes. Eur J Pharmacol 2006, 535:212-219.
58. Kim J.W., Baek B.S., Kim Y.K., Herlihy J.T., Ikeno Y., Yu B.P., et al. Gene expression of cyclooxygenase in the aging heart. J Gerontol A Biol Sci Med Sci 2001, 56:B350-B355.
59. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003, 111:1201-1209.
60. Otani H. The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal 2009, 11:1913-1928.
61. Doerries C., Grote K., Hilfiker-Kleiner D., Luchtefeld M., Schaefer A., Holland S.M., et al. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 2007, 100:894-903.
62. McNally J.S., Saxena A., Cai H., Dikalov S., Harrison D.G. Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler Thromb Vasc Biol 2005, 25:1623-1628.
63. Wencker D., Chandra M., Nguyen K., Miao W., Garantziotis S., Factor S.M., et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003, 111:1497-1504.
64. Matsuzawa A., Ichijo H. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal 2005, 7:472-481.
65. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
66. Qin F., Patel R., Yan C., Liu W. NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin. Free Radic Biol Med 2006, 40:236-246.
67. Looi Y.H., Grieve D.J., Siva A., Walker S.J., Anilkumar N., Cave A.C., et al. Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 2008, 51:319-325.
68. Artham S.M., Lavie C.J., Milani R.V., Patel D.A., Verma A., Ventura H.O. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 2009, 52:153-167.
69. Nakamura K., Fushimi K., Kouchi H., Mihara K., Miyazaki M., Ohe T., et al. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 1998, 98:794-799.
70. Hirotani S., Otsu K., Nishida K., Higuchi Y., Morita T., Nakayama H., et al. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 2002, 105:509-515.
71. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
72. Molkentin J.D., Kalvakolanu D.V., Markham B.E. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene. Mol Cell Biol 1994, 14:4947-4957.
73. Passier R., Zeng H., Frey N., Naya F.J., Nicol R.L., McKinsey T.A., et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Investig 2000, 105:1395-1406.
74. Haberland M., Montgomery R.L., Olson E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 2009, 10:32-42.
75. Saha R.N., Pahan K. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 2006, 13:539-550.
76. Hu E., Chen Z., Fredrickson T., Zhu Y., Kirkpatrick R., Zhang G.F., et al. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J Biol Chem 2000, 275:15254-15264.
77. D'Souza S.J., Pajak A., Balazsi K., Dagnino L. Ca2+ and BMP-6 signaling regulate E2F during epidermal keratinocyte differentiation. J Biol Chem 2001, 276:23531-23538.
78. Patra S.K., Patra A., Dahiya R. Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem Biophys Res Commun 2001, 287:705-713.
79. Antos C.L., McKinsey T.A., Dreitz M., Hollingsworth L.M., Zhang C.L., Schreiber K., et al. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 2003, 278:28930-28937.
80. Kook H., Lepore J.J., Gitler A.D., Lu M.M., Wing-Man Yung W., Mackay J., et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Investig 2003, 112:863-871.
81. Trivedi C.M., Luo Y., Yin Z., Zhang M., Zhu W., Wang T., et al. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3? activity. Nat Med 2007, 13:324-331.
82. Nott A., Watson P.M., Robinson J.D., Crepaldi L., Riccio A. S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 2008, 455:411-415.
83. McKinsey T.A., Zhang C.L., Olson E.N. Signaling chromatin to make muscle. Curr Opin Cell Biol 2002, 14:763-772.
84. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 2002, 110:479-488.
85. McKinsey T.A., Zhang C.L., Lu J., Olson E.N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000, 408:106-111.
86. Grozinger C.M., Schreiber S.L. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci USA 2000, 97:7835-7840.
87. Backs J., Olson E.N. Control of cardiac growth by histone acetylation/deacetylation. Circ Res 2006, 98:15-24.
88. Kirsh O., Seeler J.S., Pichler A., Gast A., Muller S., Miska E., et al. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J 2002, 21:2682-2691.
89. Potthoff M.J., Wu H., Arnold M.A., Shelton J.M., Backs J., McAnally J., et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Investig 2007, 117:2459-2467.
90. Ago T., Liu T., Zhai P., Chen W., Li H., Molkentin J.D., et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 2008, 133:978-993.
91. Grieve D.J., Byrne J.A., Siva A., Layland J., Johar S., Cave A.C., et al. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol 2006, 47:817-826.
92. Zhang M., Brewer A.C., Schroder K., Santos C.X., Grieve D.J., Wang M., et al. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA 2010, 107:18121-18126.
93. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000, 87:179-183.
94. Ushio-Fukai M., Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 2004, 264:85-97.
95. Haurani M.J., Pagano P.J. Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease?. Cardiovasc Res 2007, 75:679-689.
96. Sorescu D., Weiss D., Lassegue B., Clempus R.E., Szocs K., Sorescu G.P., et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002, 105:1429-1435.
97. Bedard K., Lardy B., Krause K.H. NOX family NADPH oxidases: not just in mammals. Biochimie 2007, 89:1107-1112.
98. Li J.M., Shah A.M. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 2002, 277:19952-19960.
99. Van Buul J.D., Fernandez-Borja M., Anthony E.C., Hordijk P.L. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 2005, 7:308-317.
100. Petry A., Djordjevic T., Weitnauer M., Kietzmann T., Hess J., Gorlach A. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 2006, 8:1473-1484.
101. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006, 7:589-600.
102. Kinnula V.L., Fattman C.L., Tan R.J., Oury T.D. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005, 172:417-422.
103. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000, 21:49-98.
104. Ha H., Lee H.B. Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol 2003, 14:S246-S249.
105. An S.J., Boyd R., Zhu M., Chapman A., Pimentel D.R., Wang H.D. NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts. Cardiovasc Res 2007, 75:702-709.
106. Johar S., Cave A.C., Narayanapanicker A., Grieve D.J., Shah A.M. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 2006, 20:1546-1548.
107. Sharma P., Chakraborty R., Wang L., Min B., Tremblay M.L., Kawahara T., et al. Redox regulation of interleukin-4 signaling. Immunity 2008, 29:551-564.
108. Buggisch M., Ateghang B., Ruhe C., Strobel C., Lange S., Wartenberg M., et al. Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase. J Cell Sci 2007, 120:885-894.
109. Schmelter M., Ateghang B., Helmig S., Wartenberg M., Sauer H. Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation. FASEB J 2006, 20:1182-1184.
110. Heymes C., Bendall J.K., Ratajczak P., Cave A.C., Samuel J.L., Hasenfuss G., et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 2003, 41:2164-2171.
111. Auzat I., Chapuy-Regaud S., Le Bras G., Dos Santos D., Ogunniyi A.D., Le Thomas I., et al. The NADH oxidase of Streptococcus pneumoniae: its involvement in competence and virulence. Mol Microbiol 1999, 34:1018-1028.
112. Loya F., Yang Y., Lin H., Goldwasser E., Albitar M. Transgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxia. Blood 1994, 84:1831-1836.
113. Lacombe C., Da Silva J.L., Bruneval P., Fournier J.G., Wendling F., Casadevall N., et al. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Investig 1988, 81:620-623.
114. Lee Y.M., Kim B.J., Chun Y.S., So I., Choi H., Kim M.S., et al. NOX4 as an oxygen sensor to regulate TASK-1 activity. Cell Signal 2006, 18:499-507.